VAERS reports by lot

GSK Varicella/Shingles lot H2PE2: VAERS reports

59 VAERS reports list lot H2PE2 as a GSK Varicella/Shingles vaccine, received between 2022-02-04 and 2024-05-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
59
Reports
2%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1128%
Musculoskeletal615%
Neurological513%
Injection-site / Local reaction513%
Dermatological (non-injection-site)410%
Allergic / Anaphylactic38%
Respiratory25%
Gastrointestinal25%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 10).

District of Columbia32
Pennsylvania5
California4
Maryland2
New Jersey2
Ohio2
Indiana1
Massachusetts1
New York1
Delaware1

Reports by month received

2022-027
2022-036
2022-052
2022-061
2022-101
2023-071
2023-128
2024-017
2024-0216
2024-045
2024-055

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.